Video Makes Baseless Claim About Insurance Coverage of Vaccinated Frenchman

SciCheck Digest

COVID-19 vaccines have been found to be safe and effective in trials and real-world conditions. Yet an online video baselessly claims a French life insurer refused to pay benefits for a man who died after receiving the vaccine because the insurer deemed it “a medical experiment.” It also falsely claims that the same has happened in the U.S.

More than half a billion doses of COVID-19 vaccines have now been administered in the U.S. and only a few, very rare, safety concerns have emerged. The vast majority of people experience only minor, temporary side effects such as pain at the injection site, fatigue, headache, or muscle pain — or no side effects at all. As the Centers for Disease Control and Prevention has said, these vaccines “have undergone and will continue to undergo the most intensive safety monitoring in U.S. history.”

A small number of severe allergic reactions known as anaphylaxis, which are expected with any vaccine, have occurred with the authorized and approved COVID-19 vaccines. Fortunately, these reactions are rare, typically occur within minutes of inoculation and can be treated. Approximately 5 per million people vaccinated have experienced anaphylaxis after a COVID-19 vaccine, according to the CDC.

To make sure serious allergic reactions can be identified and treated, all people receiving a vaccine should be observed for 15 minutes after getting a shot, and anyone who has experienced anaphylaxis or had any kind of immediate allergic reaction to any vaccine or injection in the past should be monitored for a half hour. People who have had a serious allergic reaction to a previous dose or one of the vaccine ingredients should not be immunized. Also, those who shouldn’t receive one type of COVID-19 vaccine should be monitored for 30 minutes after receiving a different type of vaccine.

There is evidence that the Pfizer/BioNTech and Moderna mRNA vaccines may rarely cause inflammation of the heart muscle (myocarditis) or of the surrounding lining (pericarditis), particularly in male adolescents and young adults.

Based on data collected through August 2021, the reporting rates of either condition in the U.S. are highest in males 16 to 17 years old after the second dose (105.9 cases per million doses of the Pfizer/BioNTech vaccine), followed by 12- to 15-year-old males (70.7 cases per million). The rate for 18- to 24-year-old males was 52.4 cases and 56.3 cases per million doses of Pfizer/BioNTech and Moderna vaccines, respectively.

Health officials have emphasized that vaccine-related myocarditis and pericarditis cases are rare and the benefits of vaccination still outweigh the risks. Early evidence suggests these myocarditis cases are less severe than typical ones. The CDC has also noted that most patients who were treated “responded well to medicine and rest and felt better quickly.”

The Johnson & Johnson vaccine has been linked to an increased risk of rare blood clots combined with low levels of blood platelets, especially in women ages 30 to 49. Early symptoms of the condition, which is known as thrombosis with thrombocytopenia syndrome, or TTS, can appear as late as three weeks after vaccination and include severe or persistent headaches or blurred vision, leg swelling, and easy bruising or tiny blood spots under the skin outside of the injection site.

According to the CDC, TTS has occurred in around 4 people per million doses administered. As of early April, the syndrome has been confirmed in 60 cases, including nine deaths, after more than 18.6 million doses of the J&J vaccine. Although TTS remains rare, because of the availability of mRNA vaccines, which are not associated with this serious side effect, the FDA on May 5 limited authorized use of the J&J vaccine to adults who either couldn’t get one of the other authorized or approved COVID-19 vaccines because of medical or access reasons, or only wanted a J&J vaccine for protection against the disease. Several months earlier, on Dec. 16, 2021, the CDC had recommended the Pfizer/BioNTech and Moderna shots over J&J’s.

The J&J vaccine has also been linked to an increased risk of Guillain-Barré Syndrome, a rare disorder in which the immune system attacks nerve cells. Most people who develop GBS fully recover, although some have permanent nerve damage and the condition can be fatal.

Safety surveillance data suggest that compared with the mRNA vaccines, which have not been linked to GBS, the J&J vaccine is associated with 15.5 additional GBS cases per million doses of vaccine in the three weeks following vaccination. Most reported cases following J&J vaccination have occurred in men 50 years old and older.

Link to this

Full Story

Four COVID-19 vaccines administered in the U.S. have been authorized or approved for use by the Food and Drug Administration following extensive testing, as we’ve previously written. (For more information, see SciCheck’s articles on the Pfizer/BioNTech, Moderna, Johnson & Johnson and Novavax vaccines.)

Pfizer/BioNTech and Moderna were the first vaccines to receive the go-ahead in the U.S., receiving emergency use authorization in December 2020 and full FDA approval, respectively, in August 2021 and January 2022. Both vaccines use modified messenger RNA, or mRNA, which instruct cells to make spike proteins that will trigger an immune response.

Though the process from development to approval was faster than usual for a variety of reasons, including past investment and research in mRNA technology, scientists said safety was not compromised. The safety of the vaccines has been proven not only in clinical trials, but in real-world conditions.

There have been more than 600 million doses of COVID-19 vaccines administered in the U.S., and serious adverse events have been very rare. Most people experience minor side effects, such as temporary pain at the injection site, fatigue or muscle pain, or no side effects at all.

U.S. insurance companies do not consider the vaccines experimental, and have not refused payouts to beneficiaries of policyholders who died after receiving the vaccine, as we’ve written.

But a video shared on Instagram claims a French insurance company refused to pay life insurance benefits to the beneficiaries of an “elderly, wealthy” man who died after receiving the COVID-19 vaccine because the insurer deemed the vaccine “a medical experiment.”

The video was produced by America’s Frontline Doctors, a group that has spread misinformation about COVID-19 since 2020. It first appeared on March 14, 2022, as part of the group’s “Frontline Flash” video series, which carries the slogan, “The real story of fake news in 120 seconds or less.”

Dr. Peterson Pierre, a dermatologist and narrator of the video, says that a French judge ruled the man’s death a suicide because he knew the vaccine had risks and “willingly chose” to get it. While he speaks, a headline appears on the screen that says: “France: Court rules COVID vaccine-related death a suicide.”

The article about the French case featured in the video appeared in the Athens News on Jan. 14, citing the website Unser Mitteleuropa as the source of the report. Netzpolitik.org, a German website about “digital freedom rights,” describes Unser Mitteleuropa as a “right-hand portal” that promotes disinformation about COVID-19.

In the video, Pierre goes on to say: “Suicides, along with death from experimental drugs, are not covered by life insurance.” The “American Life Insurance Council,” Pierre claims, allows U.S. companies to deny payment if someone dies as the result of the COVID-19 vaccine.

But there is no basis for any of those claims. The video even gets the name of the American organization wrong; it’s the American Council of Life Insurers, or ACLI.

In France, as in the U.S., COVID-19 vaccines have been approved.

“The rumor that insurance companies would refuse to pay life insurance if the deceased had been vaccinated against Covid-19 continues to circulate on social networks. This is false information,” Jean-Baptiste Mounier, a spokesperson for the French Federation of Insurers, told us in a Sept. 26 email.

The Spanish fact-checking organization Maldita.es, which also debunked the video, reported that in French media there’s no mention of the incident alleged in the video.

The French Ministry of Justice has no record of the case and the ACLI refuted the claim, according to Reuters. “The Ministry of Justice has no knowledge of this alleged claim concerning a French court supporting the decision of insurance companies’ refusal to pay out for life insurance due to death following COVID-19 vaccine,” a ministry representative told Reuters.

No U.S. insurer or court would consider a death linked to a prescribed medication such as a vaccine “tantamount to suicide,” Glenn Kantor, a partner at Kantor & Kantor LLP, a Los Angeles-based law firm specializing in health, life and disability insurance cases, told us in a phone interview. That’s because people who get vaccinated are “trying to save their life, not end it,” he said.

Basic life insurance policies in the U.S. generally pay for any death, regardless of cause, with suicides usually covered after the person has held the policy for two years, Kantor also said.

The video isn’t the first to make the claim that insurers refused to pay when someone has died after receiving the COVID-19 vaccine. ACLI last year debunked the claim that U.S. insurers don’t cover alleged vaccine-related deaths.

“The fact is that life insurers do not consider whether or not a policyholder has received a COVID vaccine when deciding whether to pay a claim,” Paul Graham, senior vice president for policy development at the ACLI, said in a May 21, 2021, statement that he emailed to us at the time for a story on a claim about denied benefits in the U.S.

“Life insurance policy contracts are very clear on how policies work, and what cause, if any, might lead to the denial of a benefit. A vaccine for COVID-19 is not one of them,” Graham said.

And state insurance regulators in Louisiana, New York, and Texas have all issued statements refuting the claims, according to Reuters.

America’s Frontline Doctors couldn’t be reached for comment about the video’s baseless claims.

Correction, Sept. 29: We updated this article to correct the number of COVID-19 vaccine doses administered in the United States.

Editor’s note: SciCheck’s COVID-19/Vaccination Project is made possible by a grant from the Robert Wood Johnson Foundation. The foundation has no control over FactCheck.org’s editorial decisions, and the views expressed in our articles do not necessarily reflect the views of the foundation. The goal of the project is to increase exposure to accurate information about COVID-19 and vaccines, while decreasing the impact of misinformation.

Sources

Hale Spencer, Saranac. “Posts Misrepresent Data to Falsely Claim Italy Reduced Its COVID-19 Death Count.” FactCheck.org. 18 Nov 2021.

McDonald, Jessica. “Q&A on COVID-19 Vaccines.” FactCheck.org. Updated 16 Jul 2021.

NetzPolitik.net. “Disinformation from Austria.” 23 Mar 2021.

American Council of Life Insurers. “American Council of Life Insurers (ACLI): Policyholders’ COVID-19 Vaccine Status Does Not Affect Life Insurance Claims.” Press release. 16 Sep 2021.

Corti, Delphine. “Es falso que la justicia francesa eximió a “una compañía de seguros de cubrir la muerte de un vacunado por considerar un suicidio que se inyectara un producto experimental.” Chequedo. 1 Feb 2022.

COVID-19. Vaccine Tracker. 9 Vaccines Approved for Use in France. Accessed 26 Sep 2022.

Maldita. “No, la justicia francesa no ha eximido a “una compañía de seguros de cubrir la muerte de un vacunado” frente a la COVID-19 “por considerar un suicidio que se inyectara un producto experimental.” Maldita.es. 21 Jan 2022.

Reuters. “Fact Check — Life Insurance Not Denied on Grounds of COVID-19 Vaccination.” 31 Mar 2022.

Gambardello, Joseph A. “Insurance Companies Provide Coverage After COVID-19 Vaccination.” FactCheck.org. 25 May 2021.

Kantor, Glenn. Partner at Kantor & Kantor LLP. Phone interview with FactCheck.org. 21 Sep 2022.